Peter Ulvskjold appointed as new Atlas Antibodies’ CEO

Atlas Antibodies is pleased to announce Peter Ulvskjold as the new CEO with effect from the 1st of October 2022.

Peter Ulvskjold joined Atlas Antibodies from his role as Chief Transformation Officer at ConvaTec.


Prior to that, Peter worked for 17 years in Novo Nordisk holding various leadership positions globally.

He has extensive experience in building organizations, expanding business and driving a profitable growth journey in both the MedTech and pharmaceutical industry.

Peter Holds and M.Sc. in Economics and Business Administration from Aarhus University.